ADIPOQ and metabolic disease: Therefore, plasma/serum adiponectin levels and genomic DNA polymorphisms in the AdipoQ gene can be used as the biomarkers for early diagnosis and clinic prediction of diabetes, obesity, diabetic complications and other metabolic disorders.